Governance of ERN-EuroBloodNet is based on three main governing bodies: the ERN Coordination, the Board of the Network (BoN), and the Scientific and Strategic Board (SSB). They are continuously supported by the ERN-EuroBloodNet Stakeholders Group.
Coordinator
Oncological Hub Chair
AP-HP, Hôpital St. Louis, Paris
Co-coordinator
Non-oncological Hub Chair
Hôpital ERASME-CUB, LHUB-ULB, Brussels
Scientific Director & ENROL Coordinator
University Hospital Vall d'Hebron
Vall d'Hebron Research Institute, Barcelona
Scientific Manager
University Hospital Vall d'Hebron
Vall d'Hebron Research Institute, Barcelona
Educational & Patients Program Manager
AP-HP
Hôpital St. Louis, Paris
CPMS & Educational Manager for Health Professionals
Hôpital ERASME-CUB, LHUB-ULB, Brussels
ERN Operations manger
University Hospital Vall d'Hebron
Vall d'Hebron Research Institute, Barcelona
Dissemination Manager
University Hospital Vall d'Hebron
Vall d'Hebron Research Institute, Barcelona
Educational Actions Supporting Officer
AP-HP
Hôpital St. Louis, Paris
ENROL Project Manager
University Hospital Vall d'Hebron
Vall d'Hebron Research Institute, Barcelona
ENROL Biostatistician & Data Manager
University Hospital Vall d'Hebron
Vall d'Hebron Research Institute, Barcelona
ENROL IT Manager
University Hospital Vall d'Hebron
Vall d'Hebron Research Institute, Barcelona
Administrative Assistant
University Hospital Vall d'Hebron
Vall d'Hebron Research Institute, Barcelona
ERN-EuroBloodNet is officially coordinated by AP-HP. Since its beginning 2017, the expanded Coordination team included three main medical/scientist hubs of coordination to ensure the deployment of the ERN strategic plan and the achievement of its results:
Staff members conforming ERN-EuroBloodNet Coordination team are assigned to the different coordination hubs based on their main role and activities. The Coordination team is in charge of assuring the proper operational management of the network and the smooth functioning among the key players.
The Board of the Network (BoN) is composed by all Members and Affiliated Partners representatives, and the ERN European Patients Advocacy Groups (ePAGs).
The BoN, as the decision-making body of the ERN, is responsible for:
All member representatives, as part of the BoN, have the obligation to:
The Scientific and Strategic Board (SSB) is composed by:
The main function of the SSB is to develop the MWP and oversee ERN-EuroBloodNet actions and assess their impact.
The three governing bodies are assisted by the ERN-EuroBloodNet Stakeholders Group (SG):
The roles of the SG are: